angiotensinconvert
enzym
identifi
host
receptor
sarscoronaviru
infect
million
worldwid
like
caus
hundr
thousand
death
util
transcriptom
data
four
cohort
taken
crohn
diseas
cd
noninflammatori
bowel
diseas
ibd
subject
observ
evid
increas
mrna
ileum
demograph
featur
associ
poor
outcom
includ
age
rais
bmi
downregul
cd
compar
control
independ
cohort
within
cd
express
reduc
inflam
ileal
tissu
also
remark
uninvolv
tissu
patient
wors
prognosi
adult
pediatr
cohort
activ
cd
small
bowel
express
restor
antitnf
therapi
particularli
antitnf
respond
collect
data
suggest
downregul
associ
inflamm
wors
outcom
cd
april
th
approxim
two
quarter
million
peopl
worldwid
confirm
coronaviru
diseas
infect
current
like
conserv
estim
implic
viru
death
caus
infect
sarscoronaviru
commonli
present
respiratori
symptom
howev
recent
report
suggest
patient
frequent
respiratori
gi
symptom
predominantli
diarrhea
nausea
proport
patient
gi
symptom
may
sole
complaint
also
concern
detect
viru
stool
may
implic
fecalor
rout
import
mode
transmiss
signific
variat
outcom
major
mild
symptom
minor
respiratori
complic
small
percentag
die
consequ
secondari
cytokin
storm
superimpos
infect
increas
age
male
gender
smoke
comorbid
elev
bodi
mass
index
bmi
implic
increas
morbid
mortal
like
factor
also
contribut
variabl
respons
understand
interest
concern
role
immunosuppress
medic
commonli
use
immunemedi
diseas
may
suscept
natur
histori
angiotensinconvert
enzym
put
receptor
entri
human
cell
molecul
interact
plausibl
candid
biolog
includ
transmembran
serin
proteas
help
prime
spike
protein
host
cell
entri
paralog
reninangiotensinaldosteron
system
raa
angiotensin
convert
enzym
ace
solut
carrier
famili
member
express
depend
express
alter
fibrot
pulmonari
diseas
lung
tissu
smoker
abundantli
express
small
bowel
sb
compar
tissu
includ
whole
blood
aim
determin
factor
includ
inflamm
drug
treatment
influenc
express
sb
crohn
diseas
cd
patient
nonibd
inflammatori
bowel
diseas
control
investig
share
diseas
biolog
ibd
dataset
previous
publish
detail
approv
found
public
genom
technolog
access
center
washington
univers
st
loui
mo
gener
dataset
washu
cohort
method
use
gener
microarray
cohort
data
previous
describ
washu
cohort
rnaseq
librari
prepar
sequenc
read
align
perform
sequenc
done
illumina
illumina
san
diego
ca
use
singl
read
extend
base
cohort
total
rna
process
sigma
seqplex
creat
amplifi
dscdna
follow
tradit
illumina
librari
prepar
uniqu
dual
index
librari
run
flow
cell
use
singleend
base
read
run
gener
approxim
read
pass
filter
thu
averag
million
read
per
librari
gener
data
gener
method
three
cohort
risk
ifx
ust
publish
previous
tabl
show
geo
access
number
two
three
publish
cohort
use
studi
dataset
washu
cohort
access
arrayexpress
method
use
process
microarray
data
cohort
previous
describ
pipelin
use
rnaseq
data
process
normal
cohort
similar
one
use
washu
cohort
previous
describ
rnaseq
data
normal
result
rpkm
valu
gener
analysi
washu
normal
data
gener
fpkm
method
use
process
rnaseq
data
risk
cohort
also
describ
previous
data
process
method
ifx
cohort
ust
cohort
describ
prior
public
normal
process
data
cohort
risk
ifx
ust
download
use
access
number
avail
geo
seri
matrix
file
clean
annot
geneid
clean
process
data
washu
along
respect
metadata
avail
inhous
metadata
avail
differ
transcriptom
cohort
use
compil
tabl
clinic
phenotyp
data
avail
includ
age
collect
gender
smoke
statu
diseas
statu
cd
subphenotyp
diseas
recurr
surgeri
cohort
includ
age
collect
gender
smoke
statu
diseas
statu
cd
subphenotyp
washu
cohort
data
extract
clinic
chart
includ
age
collect
gender
diseas
statu
smoke
bmi
surgeri
risk
cohort
pediatr
incept
cohort
data
collect
prospect
transcriptom
dataset
metadata
risk
cohort
download
ncbi
geosra
use
access
number
age
collect
gender
diseas
diagnosi
includ
inform
involv
versu
unaffect
cd
complic
data
avail
prospect
follow
cd
subphenotyp
metadata
tabl
includ
sever
versu
mild
refractori
involv
versu
uninvolv
risk
diseas
complic
risk
metadata
ifx
ust
cohort
download
respect
geo
access
number
platform
annot
normal
gene
express
phenotyp
metadata
extract
use
r
packag
geoqueri
librari
phenotyp
metadata
tabl
use
identifi
categori
tissu
type
noninvolvedinflam
termin
ileum
biopsi
tissu
sampl
diseas
statu
control
cd
uc
time
point
defin
week
week
treatment
treatment
type
etc
avail
per
cohort
univari
model
fit
respons
avail
demograph
data
age
gender
bmi
surgeri
smoke
statu
predictor
cohort
similar
pipelin
follow
clinic
predictor
diseas
statu
cd
sever
subgroup
recurr
treatment
avail
given
cohort
follow
fit
multivari
model
express
respons
avail
predictor
within
cohort
washu
risk
cohort
multivari
model
also
fit
express
relev
gene
ace
examin
relationship
express
diseas
recurr
avail
multivari
model
age
gender
first
two
princip
compon
genotyp
data
calcul
use
genet
data
publish
previous
also
examin
associ
cd
diseas
behavior
avail
risk
use
age
gender
covari
statist
packag
glm
r
version
use
perform
univari
multivari
associ
p
cutoff
statist
signific
case
graphpad
prism
graphpad
la
jolla
ca
also
use
perform
statist
analysi
appropri
parametr
nonparametr
statist
test
appli
coexpress
analysi
gene
interest
involv
either
ibd
pathogenesi
high
probabl
sar
virushost
proteinprotein
interact
perform
use
cohort
genom
annot
candid
gene
interest
extract
probetranscript
level
platform
annot
file
r
base
genomicfeatur
packag
bioconductor
statist
packag
glm
use
fit
multivari
linear
regress
model
gene
pair
includ
covari
age
collect
gender
avail
p
cutoff
statist
signific
full
list
gene
examin
coexpress
analysi
avail
tabl
differ
gene
express
age
bmi
diseas
smoke
gender
examin
mrna
express
age
subject
time
specimen
collect
avail
express
abundantli
express
transcript
isoform
associ
age
collect
washu
cohort
figur
higher
express
associ
older
age
collect
observ
cd
nonibd
control
associ
age
trend
toward
signific
pediatr
risk
cohort
figur
see
statist
signific
associ
age
microarray
base
cohort
figur
well
cohort
combin
data
rnaseq
platformbas
washu
risk
cohort
gener
foldchang
gene
express
respect
housekeep
gene
gapdh
respect
cohort
valid
posit
correl
age
specimen
collect
figur
washu
cohort
observ
strong
associ
express
bmi
cd
nonibd
control
subject
higher
bmi
elev
express
p
linear
regress
figur
see
signific
associ
gender
washu
risk
cohort
figur
tabl
howev
observ
higher
ileal
express
femal
cohort
figur
consist
similar
observ
gtex
find
statist
associ
smoke
express
adult
cohort
tabl
figur
although
suggest
trend
toward
higher
express
cohort
figur
data
nonibd
control
comparison
avail
washu
risk
cohort
washu
cohort
figur
express
lower
cd
compar
nonibd
control
univari
model
diseas
statu
predictor
statist
signific
lower
express
cd
versu
control
washu
cohort
tabl
risk
cohort
median
express
cd
uc
control
statist
differ
p
figur
univari
model
express
diseas
statu
indic
lower
cd
compar
control
well
cd
compar
uc
tabl
multivari
model
diseas
statu
predictor
statist
signific
trend
toward
signific
lower
express
cd
versu
control
washu
cohort
tabl
cohort
observ
bmi
strongest
predictor
express
adjust
age
collect
diseas
statu
gender
risk
cohort
observ
lower
express
cd
compar
control
uc
adjust
age
diagnosi
gender
tabl
age
diagnosi
significantli
associ
express
adjust
diseas
statu
gender
risk
cohort
tabl
differ
small
bowel
gene
express
diseas
subphenotyp
risk
cohort
biopsi
taken
macroscop
uninflam
tissu
small
bowel
express
lower
cd
small
bowel
involv
icd
contrast
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
cd
small
bowel
uninvolv
cd
colon
cd
ccd
figur
tabl
median
express
statist
differ
control
uc
icd
ccd
p
figur
also
found
trend
toward
associ
express
diagnosi
develop
complic
diseas
year
without
adjust
age
gender
figur
associ
express
diagnosi
subsequ
develop
complic
diseas
becam
signific
year
figur
versu
versu
adjust
age
gender
previous
report
transcriptomicsbas
subgroup
vari
diseas
sever
cohort
found
sever
refractori
subgroup
associ
increas
recurr
faster
time
recurr
second
surgeri
compar
mild
refractori
subgroup
found
gene
express
probe
lower
versu
subgroup
correct
p
cohort
also
found
lower
gene
express
subject
diseas
recurr
surgeri
adjust
age
gender
first
two
princip
compon
genotyp
data
figur
relat
implic
gene
inflammatori
cytokin
known
ibd
target
due
role
also
examin
differenti
express
relat
gene
ace
control
versu
cd
washu
tabl
risk
cohort
tabl
similar
express
ace
lower
cd
versu
nonibd
control
washu
risk
cohort
tabl
found
greater
express
proteas
cd
compar
nonibd
control
lower
cd
compar
control
risk
cohort
tabl
coexpress
analysi
observ
sever
gene
correl
express
cd
cohort
tabl
includ
coeffici
p
p
invers
correl
coeffici
p
cd
cohort
tabl
effect
anticytokin
therapi
express
perform
univari
analys
cohort
small
bowel
sampl
collect
preand
postexposur
antitnf
infliximab
ustekinumab
ifx
ust
cohort
queri
effect
anticytokin
monoclon
antibodi
use
treatment
ibd
small
bowel
express
ust
cohort
observ
trend
toward
increas
express
pretreat
week
posttreat
week
sampl
inflam
uninflam
tissu
figur
ust
cohort
metadata
respons
treatment
unavail
ifx
cohort
express
significantli
increas
infliximab
induct
phenomenon
statist
signific
individu
respond
treatment
nonrespond
figur
consist
tissu
cell
type
specif
express
report
literatur
found
robust
express
mrna
small
bowel
ileal
tissu
non
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
ibd
control
subject
cd
observ
evid
increas
mrna
ileum
demograph
featur
associ
poor
outcom
includ
age
elev
bmi
agerel
express
may
one
reason
decreas
suscept
children
versu
adult
data
particularli
nonibd
subject
reflect
express
organ
lung
lower
express
uninflam
small
bowel
tissu
associ
recurr
surgeri
remark
tissu
taken
diagnosi
subsequ
develop
complic
diseas
year
diagnosi
cd
associ
nonibd
subject
also
relationship
express
macroand
microscop
noninflam
tissu
cd
patient
point
system
chang
influenc
mechan
case
age
increas
bmi
condit
associ
increas
immun
tone
myeloid
skew
well
increas
increas
express
lung
also
report
associ
age
specul
gi
tract
may
serv
altern
rout
uptak
find
gi
tract
may
take
increas
relev
confirm
furthermor
earli
uncontrol
evalu
secureibd
registri
suggest
patient
ibd
appear
underrepres
diagnos
compar
seen
gener
popul
northern
itali
china
data
suggest
reduc
express
subset
ibd
may
potenti
contribut
phenomenon
although
work
need
done
better
understand
observ
recent
find
suggest
men
significantli
higher
mortal
rate
observ
higher
express
men
fact
one
cohort
observ
higher
express
women
find
keep
express
women
gtex
howev
gender
differ
express
may
tissu
depend
reflect
tissuespecif
escap
xinactiv
differ
enzym
activ
secondari
effect
sex
hormon
also
describ
whether
men
suscept
like
experi
wors
outcom
remain
unknown
saw
trend
toward
increas
express
smoker
one
cohort
perhap
reflect
limit
power
given
rel
low
frequenc
smoker
popul
part
reninangiotensinaldosteron
system
raa
specul
play
paradox
role
diseas
progress
although
higher
express
increas
viral
uptak
host
physiolog
signific
antiinflammatori
role
paradox
summar
figur
relat
cd
express
requir
neutral
patholog
effect
increas
angiotensinii
angii
classic
raa
pathway
convert
ang
ii
lung
express
protect
diseas
pulmonari
fibrosi
lung
injuri
asthma
consist
report
literatur
antiinflammatori
role
report
within
cd
reduc
small
bowel
express
associ
inflamm
sever
diseas
higher
rate
diseas
relaps
even
measur
noninflam
tissu
might
downregul
sever
cd
lead
inflamm
intestin
injuri
express
gut
necessari
maintain
amino
acid
homeostasi
antimicrobi
peptid
express
healthi
intestin
microbiom
mice
prone
develop
coliti
induc
model
express
amino
acid
transport
b
sb
depend
presenc
act
chaperon
membran
traffick
accordingli
find
express
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
decreas
cd
along
notabl
lower
level
select
associ
lower
tryptophan
level
small
bowel
cd
figur
adapt
prior
literatur
raa
pathway
dysregul
tryptophan
metabol
link
system
inflamm
biolog
mechan
link
level
tryptophan
diseas
intestin
inflamm
obes
complex
includ
host
microbi
product
bioactiv
tryptophan
metabolit
select
role
metabolit
molecular
process
energi
checkpoint
transcript
control
inflamm
pathway
explor
mechan
defici
cd
may
distil
network
could
serv
protect
pathway
ibd
intriguingli
complic
may
common
ibd
patient
activ
diseas
studi
role
mechan
play
acut
infect
complic
must
prioriti
research
commun
elev
level
may
promot
tissu
propag
viru
theori
could
promot
diseas
sever
howev
secondari
cytokin
storm
like
promot
tissu
injuri
via
mechan
independ
viral
propag
process
may
independ
express
altern
antiinflammatori
properti
may
play
role
protect
secondari
cytokin
storm
due
interact
interest
treatment
modul
studi
examin
product
sarscov
found
viral
entri
modul
enzym
tace
via
cytoplasm
domain
caus
tissu
damag
increas
product
identifi
level
restor
infliximab
therapi
statist
signific
antitnf
respond
also
observ
increas
express
ustekinumab
therapi
inflam
tissu
although
chang
achiev
statist
signific
invers
relationship
inflammatori
cytokin
restor
enhanc
level
respons
antitnf
point
toward
antiinflammatori
function
howev
work
need
delin
relationship
determin
whether
antitnf
could
effect
modul
secondari
cytokin
storm
associ
final
examin
coexpress
set
candid
gene
potenti
target
novel
repurpos
drug
exampl
analysi
reveal
consist
coexpress
two
cohort
identifi
candid
target
drug
hydroxychloroquin
sever
clinic
trial
test
efficaci
hydroxychloroquin
treat
addit
identifi
express
consist
correl
express
contrast
show
consist
invers
relationship
select
jak
inhibitor
avail
develop
baricitinib
inhibitor
test
base
antiinflammatori
properti
possibl
role
inhibit
endocytosi
viral
entri
observ
cooccurr
provid
support
test
compound
summar
observ
associ
variou
demograph
clinic
factor
multipl
ileal
transcriptom
dataset
associ
larg
consist
demograph
criteria
associ
wors
outcom
also
report
impair
gene
express
lead
wors
outcom
cd
evid
implic
pathway
protect
tryptophandepend
antiinflammatori
mechan
sever
ibd
antitnf
perhap
may
restor
level
context
inflamm
reduct
suggest
restor
pathway
may
mechan
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
drug
promot
recoveri
ibd
work
support
potenti
paradox
function
inflamm
infect
individu
higher
express
may
increas
infect
like
antiinflammatori
antifibrot
function
may
play
import
role
prevent
secondari
cytokin
storm
seen
individu
well
prevent
develop
complic
diseas
ibd
antitnf
therapi
well
immun
target
therapi
may
modul
process
requir
urgent
investig
cedarssinai
financi
interest
prometheu
bioscienc
inc
compani
access
data
specimen
cedarssinai
miriad
biobank
includ
data
specimen
use
studi
seek
develop
commerci
product
dpbm
jb
srt
stock
prometheu
bioscienc
inc
aap
dl
jb
srt
dpbm
consult
prometheu
bioscienc
inc
dpbm
consult
gilead
pfizer
boehring
ingelheim
qu
biolog
bridg
biotherapeut
receiv
grant
support
janssen
tss
consult
janssen
boehring
ingelheim
genentech
takeda
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tabl
tabl
detail
four
transcriptom
cohort
use
studi
associ
avail
demograph
diseas
statu
see
text
detail
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
preprint
h
h
e
l
c
e
l
n
k
n
c
l
n
u
r
n
c
r
b
l
e
c
l
g
n
n
e
n
l
n
f
l
n
n
u
r
e
p
c
r
g
r
e
l
u
e
p
e
c
f
c
n
c
r
n
p
r
e
r
p
r
n
e
r
c
e
n
c
l
l
e
c
r
n
f
f
e
r
e
n
l
l
n
e
r
c
w
h
h
r
n
u
p
u
n
g
r
e
n
e
r
l
g
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
figur
associ
diseas
subgroup
risk
cohort
express
lower
involv
cd
icd
compar
uninvolv
cd
ccd
mannwhitney
test
median
express
statist
differ
control
uc
icd
ccd
p
kruskallw
test
red
bar
indic
mean
b
risk
cohort
express
diagnosi
lower
patient
develop
complic
diseas
strictur
penetr
year
compar
patient
remain
uncompl
inflammatori
year
followup
red
bar
indic
mean
associ
becam
signific
year
diagnosi
versu
versu
adjust
age
gender
c
cohort
lower
gene
express
observ
subject
diseas
recurr
surgeri
adjust
age
gender
princip
compon
pc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
figur
figur
univari
analysi
ibd
medic
level
ust
cohort
ileal
inflam
sampl
week
wk
wk
test
b
level
ifx
cohort
control
ie
noncd
case
treat
infliximab
significantli
higher
test
crohn
ileiti
respond
cdirbefor
treatment
six
week
cdiraft
infliximab
treatment
level
significantli
restor
respond
compar
treatment
cdirbefor
test
signific
differ
seen
crohn
ileiti
nonrespond
cdinrbefor
week
cdinraft
infliximab
treatment
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
hypothes
downregul
cd
lead
low
express
henc
low
tryptophan
tip
balanc
toward
axi
inflamm
fibrosi
restor
level
lead
homeostasi
disrupt
viru
uptak
figur
adapt
prior
literatur
raa
pathway
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
